Next Article in Journal
Psoralea corylifolia L. Seed Extract Attenuates Diabetic Nephropathy by Inhibiting Renal Fibrosis and Apoptosis in Streptozotocin-Induced Diabetic Mice
Previous Article in Journal
Omega-3 Fatty Acids Supplementation Differentially Modulates the SDF-1/CXCR-4 Cell Homing Axis in Hypertensive and Normotensive Rats
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Dietary Flavonoid Intake Is Inversely Associated with Cardiovascular Disease Risk as Assessed by Body Mass Index and Waist Circumference among Adults in the United States

USDA, Agricultural Research Service, Food Surveys Research Group, 10300 Baltimore Avenue, BARC-West, Bldg 005, Rm 102, Beltsville, MD 20705-2350, USA
*
Author to whom correspondence should be addressed.
Nutrients 2017, 9(8), 827; https://doi.org/10.3390/nu9080827
Submission received: 29 June 2017 / Revised: 25 July 2017 / Accepted: 27 July 2017 / Published: 2 August 2017

Abstract

:
Although flavonoids may confer anti-inflammatory and anti-oxidant benefits, no research has examined if flavonoid intake is related to cardiovascular disease (CVD) risk defined by anthropometric measures in the USA population. This study sought to determine whether flavonoid intake is associated with combined body mass index (BMI) and waist circumference (WC) measures indicative of high, very high, or extremely high (“high+”) risk for CVD, using one day of 24-h recall data from adult (≥20 years) participants in What We Eat in America, National Health and Nutrition Examination Survey 2007–2010. Individuals were divided into categories of intake of total flavonoids and each flavonoid class, and adjusted estimates of the percentages at high+ CVD risk (based on BMI and WC, as per National Heart, Lung, and Blood Institute guidelines) were calculated. Inverse linear trends were found in percentages of adults at high+ CVD risk by intake of total flavonoids, anthocyanidins, flavan-3-ols, and flavanones (p < 0.01). For individuals in the highest (versus the lowest) intake category of anthocyanidins, flavan-3-ols, and flavanones, relative risk and confidence intervals (RR and CI, respectively) were 0.86 (99% CI: 0.79, 0.93), 0.88 (99% CI: 0.79, 0.98), and 0.89 (99% CI: 0.80, 0.98), respectively. Research is needed to determine whether the inverse relationships found in this study are applicable to CVD endpoints at the population level.

1. Introduction

Obesity is a major health concern both in the United States and abroad. In 2011–2014, 36% of USA adults were obese (body mass index (BMI) ≥ 30 kg/m2), with higher percentages among women, middle-aged and older adults, non-Hispanic (NH) blacks, and Hispanics, according to the Centers for Disease Control and Prevention, National Center for Health Statistics [1]. Both obesity and excess abdominal fat (a proxy for visceral fat, i.e., the fat surrounding internal organs) are well-documented risk factors for cardiovascular disease (CVD) and other chronic diseases, as well as for overall and disease-specific mortality [2,3,4,5]. Consequently, for nearly two decades, measurement of both BMI and waist circumference (WC; a surrogate marker of abdominal fat) has been an integral part of clinical guidelines for the assessment of overweight and obesity in USA adults [4,6]. Those guidelines contain a table of categories of risk for developing comorbidities including type 2 diabetes, hypertension, and/or CVD (hereafter termed “CVD risk”, since diabetes and hypertension both increase risk for CVD) that are based on both BMI and WC together [4,6]. For individuals with a BMI between 25 and 34.9 kg/m2 (54% of USA adults in 2007–2010) [7], WC improves the predictive power of disease risk classification over and above BMI [4].
Extensive research has been conducted to identify dietary components (beyond the consumption of excess energy) that may influence the accumulation of excess body fat. Among such dietary components are flavonoids, which are a large, diverse group of bioactive polyphenolic compounds found in plants. The six main classes of flavonoids (with examples of foods that provide them to adults in the USA) are the following: Anthocyanidins (fruits, especially berries), flavan-3-ols (tea), flavanones (citrus fruits and juices), flavones (tea, peppers, and celery), flavonols (tea, onions, and potatoes), and isoflavones (soy products) [8]. Mechanistic studies have suggested various plausible means by which flavonoids (or flavonoid-containing foods and beverages) may impact body fatness, such as by decreasing energy intake [9,10], increasing energy expenditure and fat oxidation [11], influencing macronutrient absorption and uptake [12], and inhibiting adipogenesis [13].
Although a number of studies have identified favorable associations between flavonoids (or flavonoid-rich foods/beverages/supplements) and BMI and/or WC [11,14,15,16,17,18,19,20], to our knowledge no study has been conducted to determine the relationship between flavonoid intake and CVD risk when that risk is assessed on the basis of BMI and WC together. Further, the majority of the studies that have looked at these anthropometric measures individually in relation to flavonoid intake have not analyzed dietary data from nationally representative populations. Therefore, the purpose of this study was to examine associations between intake of flavonoids (total and five classes) and CVD risk as assessed by BMI and WC jointly among adults age ≥20 years overall and by sex (males, females) via analysis of a sample representative of the United States population.

2. Methods

2.1. Data Source and Sample

Data used in this study were collected between 2007 and 2010 in What We Eat in America (WWEIA), the dietary intake component of the National Health and Nutrition Examination Survey (NHANES) [21,22]. The NHANES sample was constructed to be representative of the civilian, noninstitutionalized USA population [23]. A complex, multistage, area probability sample design was used to select persons within households. During 2007–2010, NH blacks, Hispanics, people age ≥80 years, and low income persons were oversampled to improve the accuracy of estimates for these population groups. Among adults age ≥20 years, the examination response rate (i.e., the percentage of individuals selected into the sample who were interviewed in the Mobile Examination Center (MEC)) was 70.6% in 2007–2008 and 72.2% in 2009–2010 [24].
Because the BMI and WC standards used in assessing CVD risk apply to adults, this analysis was restricted to individuals age ≥20 years. During their visit to the MEC, 11,182 adults provided an in-person 24-h dietary recall, the intake used in this analysis. Excluded were those who were pregnant and/or lactating (n = 188) or were missing weight, height, and/or WC data (456 total: 219 males, 237 females). The final analytic sample included 10,538 adults (5232 males and 5306 females). Written informed consent was obtained from all participants.
The survey protocol was approved by the National Center for Health Statistics Research Ethics Review Board. The current study was a secondary analysis and thus exempt from further review under Title 45 Code of Federal Regulations section 46.101(b).

2.2. Assessment of Flavonoid Intakes

Intakes in this study are based on foods and beverages, but not supplements, reported in WWEIA, NHANES. The data were collected by trained interviewers fluent in English and Spanish using the United States Department of Agriculture (USDA) Automated Multiple-Pass Method (AMPM) for the 24-h recall [25]. Question sequences in the AMPM were crafted to elicit sufficient detail to assign the most appropriate USDA food code from the USDA Food and Nutrient Database for Dietary Studies (FNDDS) [26,27]. Neither the AMPM nor the FNDDS was specifically designed for the analysis of flavonoid intakes. However, the AMPM’s detailed, food-specific question sequences include many questions about factors that permit discrimination between food codes differing in flavonoid content. For example, a participant who reports consuming “beans” is asked what variety of beans was consumed, which permits assignment of food codes that differ in flavonoid content (e.g., kidney beans versus pinto beans versus black beans). The AMPM collects information about foods and beverages as consumed, resulting in comprehensive estimation of the intake of flavonoid-rich foods that are typically ingredients in mixtures—such as onions, potatoes, celery, and peppers.
Versions of the FNDDS appropriate to each survey cycle were applied in assigning USDA food codes; version 4.1 was used for 2007–2008, and version 5.0 was used for 2009–2010 [27]. The USDA food code also served as the link between the WWEIA, NHANES foods/beverages and the Database of Flavonoid Values for USDA Food Codes 2007–2010 (hereafter referred to as the “Flavonoid Database”) [28], which provides values for 29 individual flavonoids, six flavonoid classes, and total flavonoids for all food codes (n = 7273) used in processing data in WWEIA, NHANES 2007–2010 [29]. Application of the Flavonoid Database to the dietary intake data yielded the Flavonoid Intake Data Files from WWEIA, NHANES 2007–2010 [28], which allow calculation of flavonoid intake estimates representative of the USA population.
Aggregate daily intakes of total flavonoids (the sum of the 29 individual flavonoids) and five of the flavonoid classes (anthocyanidins, flavan-3-ols, flavanones, flavones, and flavonols) from all foods and beverages were estimated. In addition to catechins, the flavan-3-ol class includes derived tannins (theaflavins and thearubigins) [29], but it excludes condensed tannins (proanthocyanidins) because sufficient data are not yet available for the full range of survey foods and beverages. Although included in total flavonoids, isoflavones were not analyzed separately because: (a) intakes in the USA are so low [8] that no biological effect would be expected [30]; and (b) intakes derived using the Flavonoid Database are underestimated, due to the general exclusion of isoflavone contributions from functional ingredients such as soy additives that serve as stabilizers and emulsifiers [29].
In order to assess contributions by food groups to flavonoid intakes (total and class), each food or beverage reported was classified into one of 76 mutually exclusive groups, using the appropriate versions of the WWEIA Food Categories [31] (see the “Files” tab in that reference) as a foundation.

2.3. Anthropometric Measures

On the day the in-person dietary recall was conducted, trained health technicians measured weight, height, and WC in the MEC using standardized protocols and procedures, including electronic data capture [32,33]. Body weight was measured with the participant wearing standard MEC examination clothing, and height was measured using a stadiometer. The WC measurement was taken at the top of the iliac crest, as described in the clinical guidelines [4].

2.4. Assessment of CVD Risk

As was done in the National Institutes of Health (NIH) National Heart, Lung, and Blood Institute Practical Guide [4] (see Table 2 on p. 10 of that report), categories of CVD risk in the present study are based on BMI and, for those with BMI 25–34.9 kg/m2, sex-specific WC cutoffs (>102 cm for men, >88 cm for women). WC does not affect risk classification among individuals with BMI ≥ 35.0 kg/m2. This study sought to determine flavonoid associations with any combination of BMI and WC leading to classification as being at “high”, “very high”, or “extremely high” risk (hereafter, termed “high+ CVD risk”).

2.5. Definitions of Adjustment Variables/Covariates

The analysis included a number of sociodemographic and lifestyle characteristics (all self-reported except sex) and dietary intake components as adjustment variables when assessing the relationship between CVD risk and flavonoid intake. Sociodemographic characteristics included age, sex, race/ethnicity, and family income as a percentage of poverty (also termed Poverty Income Ratio (PIR)).
Lifestyle characteristics included exercise status, smoking status, and health status. Exercise status was calculated as minutes of recreational physical activity per week, with each vigorous-intensity minute counted as two moderate-intensity minutes [34]. Smoking status was based upon whether participants reported having smoked 100 cigarettes in their lives (no = never smoker) and, if yes, whether they smoked at the time of the survey (no = former smoker, yes = current smoker). Health status was self-reported as excellent, very good, good, fair, or poor.
Dietary intake components associated with BMI and/or WC—energy, dietary fiber, and added sugars—were also included in the model. (Solid fats and refined grains were also examined but did not explain considerable variance over and above that accounted for by the other dietary components and, therefore, were omitted from the model.) The appropriate versions of the FNDDS were used to calculate intakes of energy and dietary fiber [27], and those of the USDA Food Patterns Equivalents Database to calculate intakes of added sugars [35].

2.6. Statistical Analyses

Analyses were performed using SAS©-callable SUDAAN, release 11.0 (2012; RTI International, Research Triangle Park, NC, USA), adjusting for survey design effects resulting from NHANES’ complex, multistage probability sampling [23]. Application of dietary sample weights yielded estimates representative of the USA adult population.
For total flavonoids and each flavonoid class separately, respondents were divided into four categories of intake. Estimates of anthocyanidin and flavanone intake were zero for a sizable portion of the population (34% and 35%, respectively, of all adults). For these two flavonoid classes, all individuals with zero intake were assigned to the first category, and those with non-zero intake were divided into tertiles. Dividing respondents into quartiles per se was appropriate for total flavonoids, flavan-3-ols, flavones, and flavonols, because 10% or fewer adults had zero intakes.
Adjustment variables were examined by quartile of total flavonoid intake. Significant differences among means were identified via χ2 tests of independence for the (categorical) demographic and lifestyle characteristics and via analysis of variance (ANOVA) for the (continuous) dietary intake components.
Logistic regression was employed to ascertain the likelihood of high+ CVD risk by flavonoid (total and class) intake and the associated risk ratios. Adjustment variables were added sequentially in three steps: first, energy, sex, and age; next, race/ethnicity, income, and all lifestyle characteristics; and finally, in the fully fitted model, dietary fiber and added sugars. These model-adjusted prevalence estimates and model-adjusted risk ratios were calculated using the average marginal prediction approach described by Graubard and Korn [36] and Bieler et al. [37], which is designed to permit unbiased comparisons of risk between population subgroups after controlling for differences in their covariate distributions. Orthogonal polynomial contrasts were examined to identify linear trends in the prevalence of individuals at high+ CVD risk by flavonoid intake category. Model-adjusted risk ratios comparing the prevalence estimates of high+ CVD risk in a given category of flavonoid intake relative to that of the lowest (referent) category were computed with their corresponding 99% confidence intervals. Since obesity rates differ significantly by sex [1], it was hypothesized that the percentages at high+ CVD risk would also differ by sex. Thus, the analysis was repeated, applying the fully adjusted model only, and stratified by sex, using sex-specific flavonoid intake ranges for categorization.
For all analyses, p-values < 0.01 were considered statistically significant.

3. Results

In 2007–2010, for all adults age ≥20 years, mean (median) total flavonoid intake in the first quartile was 9.3 (9.3) mg; second, 33.4 (32.0) mg; third, 104.3 (89.6) mg; and fourth, 839.4 (603.0) mg. Demographic and lifestyle characteristics and dietary intake components are shown in Table 1. All variables examined differed significantly (p < 0.01) across quartiles of total flavonoid intake. Individuals with higher total flavonoid intake were more likely to be older (≥40 years), NH white, higher income, more active, and never or former smokers and to assess their health as excellent than were those with lower flavonoid intakes. As determined by orthogonal polynomial contrasts, significant positive linear trends were found in intakes of energy and dietary fiber with increasing quartile of total flavonoids intake.
Food/beverage groups contributing 5% or more of the total intake of flavonoids (total and class) are shown in Table 2. A single beverage group, tea, provided over three-fourths of total flavonoids intake (78% of intake for all adults), and nearly all of flavan-3-ols intake (94%). Tea was also a major contributor to flavones (10%) and flavonols (37%). Four groups of berries (blueberry, cranberry, strawberry, and other), plus the berries included as ingredients in yogurt, were the primary contributors to anthocyanidin intake, as were citrus fruits and juices to flavanone intake and soy products (including protein powders and milk substitutes) to isoflavone intake. Because flavones and flavonols are found in vegetables that are ubiquitous in mixtures (e.g., onions, potatoes, celery, peppers, and parsley), mixed dishes were among the top contributors to these flavonoid classes. Generally, though not uniformly, top sources were comparable for males and females.
As shown in Table 3, in 2007–2010, 31.2% of all adults were of normal weight or underweight (BMI < 25.0) and thus classified as being at average CVD risk, with significantly (p < 0.01) fewer males than females in this risk class (27.1% vs. 35.2%). However, more overweight (BMI 25.0–29.9) males than females had normal WC (26.3% vs. 5.8%) and were thus assessed as being at only increased risk rather than high risk. Over one-half (53.0%) of all adults in the USA were at high+ CVD risk. A higher percentage of females than males was classified as being at high+ CVD risk, due to higher percentages of females in the high risk (specifically, overweight with large WC) and extremely high risk categories.
For all adults age ≥20 years, the likelihood of being classified at high+ CVD risk (assessed on the basis of BMI and WC) by category of flavonoid intake is shown in Table 4. After adjustment for all demographic and lifestyle characteristics and dietary intake components (Model 3), significant (p < 0.01) inverse linear trends were found in prevalence of high+ CVD risk by intake of total flavonoids, anthocyanidins, flavan-3-ols, and flavanones. Adults in quartile 3 of total flavonoid intake were 13% less likely to be classified at high+ CVD risk than were those in quartile 1, the referent category. The relative risk (RR) of high+ CVD risk was 8% to 14% lower among adults in categories 3 and 4 of anthocyanidin intake; 12% to 14% among those in categories 2, 3, and 4 of flavan-3-ol intake; and 11% among those in category 4 of flavanone intake. An inverse linear trend in prevalence of being classified at high+ CVD risk by quartile of flavone intake was observed after adjustment for energy, sex, and age, but that finding was attenuated after race/ethnicity and lifestyle characteristics were included in the model. No linear trend in prevalence of high+ CVD risk by flavonol intake was noted.
In analyses stratified by sex and fully adjusted (Table 5), inverse linear trends were observed in prevalence of being classified at high+ CVD risk by category of intake for total flavonoids (males only), anthocyanidins (males and females), and flavan-3-ols (males only). Males in the second, third, and fourth quartiles of total flavonoids intake were 14% to 20% less likely to be classified at high+ CVD risk than were those in the lowest quartile. The RR of high+ CVD risk was 16% lower among females in the highest category of anthocyanidin intake, and 17% to 24% among males in categories 2 to 4 of flavan-3-ol intake. No linear trends were found in prevalence of being classified at high+ CVD risk among males or females by intake of flavanones, flavones, or flavonols.

4. Discussion

In this study, relationships were identified between flavonoid intake and prevalence of being classified at high+ CVD risk based on BMI and WC in a large, nationally representative sample of USA adults. To our knowledge, this is the first study to examine the relationship between flavonoid intake and CVD risk using BMI and WC together as a marker of risk status for type 2 diabetes, hypertension, and CVD.
Intakes of total flavonoids, anthocyanidins, flavan-3-ols, and flavanones were inversely associated with high+ CVD risk, whereas intakes of flavones and flavonols were not. When stratified by sex, the inverse linear relationship between anthocyanidin intake and high+ CVD risk was maintained for both sexes, but the inverse associations for total flavonoids and flavan-3-ols were seen among males only, and no associations were seen for flavanones.
It is challenging to integrate these novel findings with the existing literature. All previous research that investigated BMI and/or WC in relation to flavonoid intake assessed these measures individually. One study that is more comparable than most was conducted on NHANES 2007–2012 data [14]. Using a proprietary flavonoid database and analyzing multivariate-adjusted models to determine associations between flavonoid intake and CVD risk factors that included BMI and WC, Kim et al. found an inverse linear trend between anthocyanidin intake and BMI, but no relationships between other flavonoid classes and BMI or between any flavonoid class and WC. Other research reporting associations between flavonoid intake and BMI and/or WC is less comparable because of methodological differences. A few studies that investigated flavonoid intake in relation to WC (as a component of metabolic syndrome) differed from the present study not only in the anatomical landmark for measurement of WC but also in the cutpoints (mostly, more restrictive) for high WC [38,39]. Numerous other studies incorporating analysis of flavonoid intake in relation to these anthropometric measures analyzed BMI and WC only as baseline characteristics, and associations were based on unadjusted or minimally adjusted (e.g., energy-adjusted) data, so their findings of inverse relationships with flavonoid intake are not truly parallel to those presented here [40,41,42].
With flavan-3-ols accounting for about 80% of total flavonoid intake in the USA [28] (see “Data Tables” in that reference), it is unsurprising that associations noted between total flavonoids and high+ CVD risk are similar to those for flavan-3-ols. Due to much higher flavan-3-ol content in tea relative to other foods, tea was the single predominant source of flavan-3-ols. Much research has been conducted linking green tea catechins (monomeric flavan-3-ols) to more favorable anthropometric measures [11,17,19,20]. One might question the relevance of those findings to the current study, since most tea consumed in the USA is black tea [43], which is higher in flavan-3-ol dimers (theaflavins) and polymers (thearubigins) and much lower in catechins relative to green tea [44]. Nevertheless, our results are consistent with that work: Individuals in the highest quartile of flavan-3-ol intake, nearly all of whom consumed tea on the intake day, were significantly less likely to be at high+ CVD risk. Moreover, the 14% reduced RRs that were also observed for individuals in quartile 3 (of whom very few consumed tea) and quartile 2 (who consumed no tea), suggest that the observed association was not merely an effect of the caffeine contained in tea (or synergy between caffeine and tea-specific flavan-3-ols), as has been suggested [18].
Longitudinal research mostly supports our finding that body measures indicative of increased CVD risk are inversely associated with intake of anthocyanidins and flavanones and/or food sources of these flavonoid classes. In the Nurses’ Health Study, Health Professionals Follow-up Study, and Nurses’ Health Study II, inverse associations between intake of anthocyanidins and weight gain were found [45]. In the same cohorts and in the European Prospective Investigation into Cancer and Nutrition Study, negative weight change or decreases in WC were observed with increased intake of berries [46] and yogurt [16,47], foods that together accounted for over 40% of anthocyanidins in the present study. However, in the Women’s Health Study, both berries [48] and yogurt [49] were associated with increased likelihood of becoming overweight or obese over time. Likewise, consumption of citrus fruits, which are major contributors of flavanones, has been found to be protective against weight gain by some [48], despite other investigations failing to detect an association between flavanone intake and weight change [45]. No long-term investigations analyzing flavonoid associations with WC specifically were located, but a meta-analysis of prospective cohort studies concluded that higher intakes of fruits, but not vegetables, were associated with lower increases in WC over time [50].
Unlike anthocyanidins, neither flavone or flavonol intake has been found to be associated with long-term weight change [45]. Conversely, some of the foods identified in the present study as contributors to these flavonoid classes have been shown to be associated with increases in BMI and/or WC. Beer, shown in Table 2 to be one of the leading sources of flavonols (particularly among males), has been associated with increases in both weight [47] and WC [16,51]. In addition, the relationship between vegetables that are sources of both flavones and flavonols and weight change and WC is not uniform across specific vegetables. Potatoes, particularly fried potatoes, are associated with weight gain [46,47] and increases in WC [52], but inconsistent results have been reported with regard to other vegetable classes [46,48]. In addition, our results indicate that a substantial proportion of flavones and flavonols are obtained from vegetables that are ubiquitous in mixed dishes, e.g., onions and peppers. Other foods that are also common ingredients in mixed dishes, such as meats and white bread, have been shown to be associated with weight gain [47] and increases in WC [16] and, thus, may mask any potential beneficial associations between those flavonoid classes and BMI and WC.
The categories of risk classification used in this study were crafted by experts based on the literature linking elevations in BMI and WC with increased risk of developing various chronic diseases [4]. Although the outcome variable in the present study was given the abbreviated description “high+ CVD risk”, it is, as indicated previously, an umbrella term that includes high, very high, and extremely high risk for not only CVD but also type 2 diabetes and hypertension [4]. Several prospective cohort studies have revealed inverse relationships between flavonoid intakes and incidence of various chronic diseases for which obesity, especially abdominal obesity, is a risk factor, e.g., heart disease [40,41,42,53], ischemic stroke [53,54], type 2 diabetes [55], and hypertension [39,56]. Our findings suggest that similar inverse associations between flavonoid intake and CVD endpoints may be found for the USA adult population as a whole. That possibility deserves further study.
This study has a number of strengths. First, findings are generalizable to the USA population as a whole due to the national representativeness of the NHANES sample, and thus are applicable to all race/ethnic, income, and education groups, including those underrepresented in many cohort studies investigating associations between flavonoid intake and health outcomes. Second, the 24-h dietary recall method used in this study, USDA’s AMPM, is highly regarded [57] and has been validated for energy and sodium intakes [25,58]. Third, the use of standardized methods and trained technicians to collect anthropometric data [32,33] enhanced the accuracy of those measurements relative to self reports. Finally, because the flavonoid composition of a wide range of foods and beverages was available, it was possible to comprehensively assess flavonoid intake from all dietary sources including mixed foods, items which made substantial contributions to several of the flavonoid classes. Failure to include these sources has been identified as a common component in the widespread underestimation of flavonoid intakes in research [59].
Some limitations are worth noting. First, the validity of using BMI and WC to assign risk has been called into question due to their inability to differentiate between visceral and subcutaneous adipose tissue [60], as well as to racial/ethnic differences in both relevant cut points [61,62] and risk prediction accuracy [62]. On the other hand, in addition to the research underlying the National Heart, Lung, and Blood Institute guidelines [4], large studies with clinical endpoints have reported superior classification of CVD risk when both BMI and WC are considered together [3,63]. Nevertheless, assessment of CVD risk on the basis of anthropometric measures alone may not accurately reflect cardiometabolic markers in some individuals [64], and could result in misclassification of risk category. Second, examination of associations between intakes of other flavonoid classes (e.g., proanthocyanidins) or other polyphenols and high+ CVD risk was impossible, because information on the content of these compounds is not yet available for the wide range of foods reported in NHANES 2007–2010. Third, underreporting is a known issue in dietary surveys [25]. However, 24-h recalls as used in the present study are often employed as the standard against which food frequency questionnaires (which are often used in flavonoids research) are evaluated to judge the completeness of their collection of flavonoids and other nutrients and dietary components [65,66,67]. Lastly, use of one day of dietary data could have resulted in some misclassification of individuals into categories of flavonoid intake, since a single 24-h recall is not necessarily reflective of usual intake. However, among the 9178 individuals in this study who provided two days of intake data, using the two-day average to assign individuals to quartiles of total flavonoid intake results in 62.4% of individuals being classified in the same category as their Day 1 classification and an additional 32.6% being classified into an adjacent category. Similar patterns were observed for the individual flavonoid classes, and for males and females separately. Thus, most individuals (95.0%) were classified similarly whether one or two 24-h recalls were employed to estimate flavonoid intake.
In conclusion, intakes of total flavonoids, anthocyanidins, flavan-3-ols, and flavanones were inversely associated with prevalence of high+ CVD risk (as assessed by BMI and WC) in a large, nationally representative sample of USA adults. An extensive body of research identifies plant foods as important components of a cardioprotective diet. Findings from this study support that conclusion, particularly with regard to foods and beverages that are rich sources of these polyphenolic compounds. Research examining whether these same associations with flavonoid intake are applicable to CVD endpoints at the population level is needed.

Author Contributions

R.S.S. designed the research; J.D.G. performed the statistical analyses; R.S.S. and C.W.E. wrote the paper and R.S.S. had primary responsibility for its final content; and A.J.M. supervised the research and provided critical input to the manuscript. All authors read and approved the final draft.

Disclaimer

Mention of trade names or commercial products in this publication is solely for the purpose of providing specific information and does not imply recommendation or endorsement by the United States Department of Agriculture.

EEO/Non-Discrimination Statement

USDA is an equal opportunity provider and employer.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Ogden, C.L.; Carroll, M.D.; Fryar, C.D.; Flegal, K.M. Prevalence of obesity among adults and youth: United States, 2011–2014. NCHS Data Brief 2015, 219, 1–8. [Google Scholar] [PubMed]
  2. Cerhan, J.R.; Moore, S.C.; Jacobs, E.J.; Kitahara, C.M.; Rosenberg, P.S.; Adami, H.O.; Ebbert, J.O.; English, D.R.; Gapstur, S.M.; Giles, G.G.; et al. A pooled analysis of waist circumference and mortality in 650,000 adults. Mayo Clin. Proc. 2014, 89, 335–345. [Google Scholar] [CrossRef] [PubMed]
  3. Balkau, B.; Deanfield, J.E.; Després, J.P.; Bassand, J.P.; Fox, K.A.; Smith, S.C., Jr.; Barter, P.; Tan, C.E.; Van Gaal, L.; Wittchen, H.U.; et al. International Day for the Evaluation of Abdominal Obesity (IDEA): A study of waist circumference, cardiovascular disease, and diabetes mellitus in 168,000 primary care patients in 63 countries. Circulation 2007, 116, 1942–1951. [Google Scholar] [CrossRef] [PubMed]
  4. National Institutes of Health, National Heart, Lung, and Blood Institute, North American Association for the Study of Obesity. The Practical Guide: Identification, Evaluation, and Treatment of Overweight and Obesity in Adults; NIH Publication No. 00-4084; NIH: Bethesda, MD, USA, 2000. Available online: https://www.nhlbi.nih.gov/files/docs/guidelines/prctgd_c.pdf (accessed on 26 June 2017).
  5. World Health Organization. Obesity: Preventing and Managing the Global Epidemic: Report of a WHO Consultation; WHO Technical Report No. 894; WHO: Geneva, Switzerland, 2000; Available online: http://apps.who.int/iris/bitstream/10665/42330/1/WHO_TRS_894.pdf?ua=1&ua=1 (accessed on 26 June 2017).
  6. National Institutes of Health, National Heart, Lung, and Blood Institute. Classification of Overweight and Obesity by BMI, Waist Circumference, and Associated Disease Risks. Available online: https://www.nhlbi.nih.gov/health/educational/lose_wt/BMI/bmi_dis.htm (accessed on 26 June 2017).
  7. National Center for Health Statistics. Table 58, Normal weight, overweight, and obesity among adults aged 20 and over, by selected characteristics: United States, selected years 1988–1994 through 2011–2014. In Health, United States, 2015: With Special Feature on Racial and Ethnic Health Disparities; NCHS: Hyattsville, MD, USA, 2016; pp. 215–221. Available online: https://www.cdc.gov/nchs/data/hus/hus15.pdf (accessed on 26 June 2017).
  8. Sebastian, R.S.; Wilkinson Enns, C.; Goldman, J.D.; Martin, C.L.; Steinfeldt, L.C.; Murayi, T.; Moshfegh, A.J. A new database facilitates characterization of flavonoid intake, sources, and positive associations with diet quality among US adults. J. Nutr. 2015, 145, 1239–1248. [Google Scholar] [CrossRef] [PubMed]
  9. Heber, D.; Zhang, Y.; Yang, J.; Ma, J.E.; Henning, S.M.; Li, Z. Green tea, black tea, and oolong tea polyphenols reduce visceral fat and inflammation in mice fed high-fat, high-sucrose obesogenic diets. J. Nutr. 2014, 144, 1385–1393. [Google Scholar] [CrossRef] [PubMed]
  10. Badshah, H.; Ullah, I.; Kim, S.E.; Kim, T.H.; Lee, H.Y.; Kim, M.O. Anthocyanins attenuate body weight gain via modulating neuropeptide Y and GABAB1 receptor in rats hypothalamus. Neuropeptides 2013, 47, 347–353. [Google Scholar] [CrossRef] [PubMed]
  11. Auvichayapat, P.; Prapochanung, M.; Tunkamnerdthai, O.; Sripanidkulchai, B.O.; Auvichayapat, N.; Thinkhamrop, B.; Kunhasura, S.; Wongpratoom, S.; Sinawat, S.; Hongprapas, P. Effectiveness of green tea on weight reduction in obese Thais: A randomized, controlled trial. Physiol. Behav. 2008, 93, 486–491. [Google Scholar] [CrossRef] [PubMed]
  12. Takahashi, A.; Shimizu, H.; Okazaki, Y.; Sakaguchi, H.; Taira, T.; Suzuki, T.; Chiji, H. Anthocyanin-rich phytochemicals from aronia fruits inhibit visceral fat accumulation and hyperglycemia in high-fat diet-induced dietary obese rats. J. Oleo Sci. 2015, 64, 1243–1250. [Google Scholar] [CrossRef] [PubMed]
  13. Moon, J.; Do, H.J.; Kim, O.Y.; Shin, M.J. Antiobesity effects of quercetin-rich onion peel extract on the differentiation of 3T3-L1 preadipocytes and the adipogenesis in high fat-fed rats. Food Chem. Toxicol. 2013, 58, 347–354. [Google Scholar] [CrossRef] [PubMed]
  14. Kim, K.; Vance, T.M.; Chun, O.K. Greater flavonoid intake is associated with improved CVD risk factors in US adults. Br. J. Nutr. 2016, 115, 1481–1488. [Google Scholar] [CrossRef] [PubMed]
  15. Rangel-Huerta, O.D.; Aguilera, C.M.; Martin, M.V.; Soto, M.J.; Rico, M.C.; Vallejo, F.; Tomas-Barberan, F.; Perez-de-la-Cruz, A.J.; Gil, A.; Mesa, M.D. Normal or high polyphenol concentration in orange juice affects antioxidant activity, blood pressure, and body weight in obese or overweight adults. J. Nutr. 2015, 145, 1808–1816. [Google Scholar] [CrossRef] [PubMed]
  16. Romaguera, D.; Ängquist, L.; Du, H.; Jakobsen, M.U.; Forouhi, N.G.; Halkjær, J.; Feskens, E.J.; van der A, D.L.; Masala, G.; Steffen, A.; et al. Food composition of the diet in relation to changes in waist circumference adjusted for body mass index. PLoS ONE 2011, 6, e23384. [Google Scholar] [CrossRef] [PubMed]
  17. Hsu, C.H.; Liao, Y.L.; Lin, S.C.; Tsai, T.H.; Huang, C.J.; Chou, P. Does supplementation with green tea extract improve insulin resistance in obese type 2 diabetics? A randomized, double-blind, and placebo-controlled clinical trial. Altern. Med. Rev. 2011, 16, 157–163. [Google Scholar] [CrossRef] [PubMed]
  18. Phung, O.J.; Baker, W.L.; Matthews, L.J.; Lanosa, M.; Thorne, A.; Coleman, C.I. Effect of green tea catechins with or without caffeine on anthropometric measures: A systematic review and meta-analysis. Am. J. Clin. Nutr. 2010, 91, 73–81. [Google Scholar] [CrossRef] [PubMed]
  19. Basu, A.; Sanchez, K.; Leyva, M.J.; Wu, M.; Betts, N.M.; Aston, C.E.; Lyons, T.J. Green tea supplementation affects body weight, lipids, and lipid peroxidation in obese subjects with metabolic syndrome. J. Am. Coll. Nutr. 2010, 29, 31–40. [Google Scholar] [CrossRef] [PubMed]
  20. Nagao, T.; Komine, Y.; Soga, S.; Meguro, S.; Hase, T.; Tanaka, Y.; Tokimitsu, I. Ingestion of a tea rich in catechins leads to a reduction in body fat and malondialdehyde-modified LDL in men. Am. J. Clin. Nutr. 2005, 81, 122–129. [Google Scholar] [PubMed]
  21. National Health and Nutrition Examination Survey: 2009–2010 Data Documentation, Codebook, and Frequencies: Dietary Interview: Individual Foods, First Day. Available online: https://wwwn.cdc.gov/nchs/nhanes/2009-2010/DR1IFF_F.htm (accessed on 26 June 2017).
  22. National Health and Nutrition Examination Survey: 2007–2008 Data Documentation, Codebook, and Frequencies: Dietary Interview: Individual Foods, First Day. Available online: https://wwwn.cdc.gov/nchs/nhanes/2007-2008/DR1IFF_E.htm (accessed on 26 June 2017).
  23. Curtin, L.R.; Mohadjer, L.K.; Dohrmann, S.M.; Kruszon-Moran, D.; Mirel, L.B.; Carroll, M.D.; Hirsch, R.; Burt, V.L.; Johnson, C.L. National Health and Nutrition Examination Survey: Sample Design, 2007–2010; Vital and Health Statistics, Series 2, Data Evaluation and Methods Research, No. 160; DHHS Publication No. (PHS) 2013-1360; DHHS, CDC, National Center for Health Statistics: Hyattsville, MD, USA, 2013. Available online: https://wwwn.cdc.gov/nchs/data/series/sr_02/sr02_160.pdf (accessed on 26 June 2017).
  24. National Center for Health Statistics. NHANES Response Rates and Population Totals. Available online: https://www.cdc.gov/nchs/nhanes/response_rates_cps.htm (accessed on 18 July 2017).
  25. Moshfegh, A.J.; Rhodes, D.G.; Baer, D.J.; Murayi, T.; Clemens, J.C.; Rumpler, W.V.; Paul, D.R.; Sebastian, R.S.; Kuczynski, K.J.; Ingwersen, L.A.; et al. The US Department of Agriculture Automated Multiple-Pass Method reduces bias in the collection of energy intakes. Am. J. Clin. Nutr. 2008, 88, 324–332. [Google Scholar] [PubMed]
  26. Raper, N.; Perloff, B.; Ingwersen, L.; Steinfeldt, L.; Anand, J. An overview of USDA’s dietary intake data system. J. Food Compos. Anal. 2004, 17, 545–555. Available online: http://hdl.handle.net/10113/20984 (accessed on 21 July 2017). [CrossRef]
  27. USDA Food Surveys Research Group. FNDDS Documentation and Databases. Available online: https://www.ars.usda.gov/northeast-area/beltsville-md/beltsville-human-nutrition-research-center/food-surveys-research-group/docs/fndds-download-databases/ (accessed on 26 June 2017).
  28. USDA Food Surveys Research Group. Flavonoid Values for USDA Survey Foods and Beverages 2007–2010. Available online: https://www.ars.usda.gov/northeast-area/beltsville-md/beltsville-human-nutrition-research-center/food-surveys-research-group/docs/fndds-flavonoid-database/ (accessed on 26 June 2017).
  29. Sebastian, R.S.; Wilkinson Enns, C.; Goldman, J.D.; Steinfeldt, L.C.; Martin, C.L.; Moshfegh, A.J. Flavonoid Values for USDA Survey Foods and Beverages 2007–2010; USA Department of Agriculture, Agricultural Research Service, Food Surveys Research Group: Beltsville, MD, USA, 2016. Available online: https://www.ars.usda.gov/ARSUserFiles/80400530/pdf/fndds/FlavonoidDB_documentation_0710.pdf (accessed on 26 June 2017).
  30. Setchell, K.D.; Cassidy, A. Dietary isoflavones: Biological effects and relevance to human health. J. Nutr. 1999, 129, 758S–767S. [Google Scholar] [PubMed]
  31. USDA Food Surveys Research Group. Dietary Methods Research: What Are WWEIA Food Categories? Available online: https://www.ars.usda.gov/northeast-area/beltsville-md/beltsville-human-nutrition-research-center/food-surveys-research-group/docs/dmr-food-categories/ (accessed on 17 July 2017).
  32. National Health and Nutrition Examination Survey (NHANES) Anthropometry Procedures Manual (January 2009). Available online: https://www.cdc.gov/nchs/data/nhanes/nhanes_09_10/BodyMeasures_09.pdf (accessed on 26 June 2017).
  33. National Health and Nutrition Examination Survey (NHANES) Anthropometry Procedures Manual (January 2007). Available online: https://www.cdc.gov/nchs/data/nhanes/nhanes_07_08/manual_an.pdf (accessed on 26 June 2017).
  34. USA Department of Health and Human Services. Appendix 1. Translating scientific evidence about total amount and intensity of physical activity into guidelines. In 2008 Physical Activity Guidelines for Americans; ODPHP Publication No. U0036; USA Department of Health and Human Services, Office of Disease Prevention and Health Promotion: Rockville, MD, USA, 2008. Available online: https://health.gov/paguidelines/pdf/paguide.pdf (accessed on 26 June 2017).
  35. USDA Food Surveys Research Group. Food Patterns Equivalents Database. Available online: https://www.ars.usda.gov/northeast-area/beltsville-md/beltsville-human-nutrition-research-center/food-surveys-research-group/docs/fped-databases/ (accessed on 26 June 2017).
  36. Graubard, B.I.; Korn, E.L. Predictive margins with survey data. Biometrics 1999, 55, 652–659. [Google Scholar] [CrossRef] [PubMed]
  37. Bieler, G.S.; Brown, G.G.; Williams, R.L.; Brogan, D.J. Estimating model-adjusted risks, risk differences, and risk ratios from complex survey data. Am. J. Epidemiol. 2010, 171, 618–623. [Google Scholar] [CrossRef] [PubMed]
  38. Grosso, G.; Stepaniak, U.; Micek, A.; Stefler, D.; Bobak, M.; Pająk, A. Dietary polyphenols are inversely associated with metabolic syndrome in Polish adults of the HAPIEE study. Eur. J. Nutr. 2017, 56, 1409–1420. [Google Scholar] [CrossRef] [PubMed]
  39. Yang, Y.J.; Kim, Y.J.; Yang, Y.K.; Kim, J.Y.; Kwon, O. Dietary flavan-3-ols intake and metabolic syndrome risk in Korean adults. Nutr. Res. Pract. 2012, 6, 68–77. [Google Scholar] [CrossRef] [PubMed]
  40. Goetz, M.E.; Judd, S.E.; Safford, M.M.; Hartman, T.J.; McClellan, W.M.; Vaccarino, V. Dietary flavonoid intake and incident coronary heart disease: The REasons for Geographic and Racial Differences in Stroke (REGARDS) study. Am. J. Clin. Nutr. 2016, 104, 1236–1244. [Google Scholar] [CrossRef] [PubMed]
  41. Cassidy, A.; Mukamal, K.J.; Liu, L.; Franz, M.; Eliassen, A.H.; Rimm, E.B. High anthocyanin intake is associated with a reduced risk of myocardial infarction in young and middle-aged women. Circulation 2013, 127, 188–196. [Google Scholar] [CrossRef] [PubMed]
  42. Mink, P.J.; Scrafford, C.G.; Barraj, L.M.; Harnack, L.; Hong, C.P.; Nettleton, J.A.; Jacobs, D.R., Jr. Flavonoid intake and cardiovascular disease mortality: A prospective study in postmenopausal women. Am. J. Clin. Nutr. 2007, 85, 895–909. [Google Scholar] [PubMed]
  43. Tea Association of the USA. Tea Fact Sheet—2016–2017. Available online: http://www.teausa.com/14655/tea-fact-sheet (accessed on 26 June 2017).
  44. Bhagwat, S.; Haytowitz, D.B. USDA Database for the Flavonoid Content of Selected Foods, Release 3.2; USA Department of Agriculture, Agricultural Research Service: Beltsville, MD, USA, 2015. Available online: https://www.ars.usda.gov/ARSUserFiles/80400525/Data/Flav/Flav3.2.pdf (accessed on 26 June 2017).
  45. Bertoia, M.L.; Rimm, E.B.; Mukamal, K.J.; Hu, F.B.; Willett, W.C.; Cassidy, A. Dietary flavonoid intake and weight maintenance: Three prospective cohorts of 124,086 US men and women followed for up to 24 years. BMJ 2016, 352, i17. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  46. Bertoia, M.L.; Mukamal, K.J.; Cahill, L.E.; Hou, T.; Ludwig, D.S.; Mozaffarian, D.; Willett, W.C.; Hu, F.B.; Rimm, E.B. Changes in intake of fruits and vegetables and weight change in United States men and women followed for up to 24 years: Analysis from three prospective cohort studies. PLoS Med. 2015, 12, e1001878. [Google Scholar] [CrossRef] [PubMed]
  47. Mozaffarian, D.; Hao, T.; Rimm, E.B.; Willett, W.C.; Hu, F.B. Changes in diet and lifestyle and long-term weight gain in women and men. N. Engl. J. Med. 2011, 364, 2392–2404. [Google Scholar] [CrossRef] [PubMed]
  48. Rautiainen, S.; Wang, L.; Lee, I.M.; Manson, J.E.; Buring, J.E.; Sesso, H.D. Higher intake of fruit, but not vegetables or fiber, at baseline is associated with lower risk of becoming overweight or obese in middle-aged and older women of normal BMI at baseline. J. Nutr. 2015, 145, 960–968. [Google Scholar] [CrossRef] [PubMed]
  49. Rautiainen, S.; Wang, L.; Lee, I.M.; Manson, J.E.; Buring, J.E.; Sesso, H.D. Dairy consumption in association with weight change and risk of becoming overweight or obese in middle-aged and older women: A prospective cohort study. Am. J. Clin. Nutr. 2016, 103, 979–988. [Google Scholar] [CrossRef] [PubMed]
  50. Schwingshackl, L.; Hoffmann, G.; Kalle-Uhlmann, T.; Arregui, M.; Buijsse, B.; Boeing, H. Fruit and vegetable consumption and changes in anthropometric variables in adult populations: A systematic review and meta-analysis of prospective cohort studies. PLoS ONE 2015, 10, e0140846. [Google Scholar] [CrossRef] [PubMed]
  51. Vadstrup, E.S.; Petersen, L.; Sørensen, T.I.; Grønbæk, M. Waist circumference in relation to history of amount and type of alcohol: Results from the Copenhagen City Heart Study. Int. J. Obes. Relat. Metab. Disord. 2003, 27, 238–246. [Google Scholar] [CrossRef] [PubMed]
  52. Krachler, B.; Eliasson, M.; Stenlund, H.; Johansson, I.; Hallmans, G.; Lindahl, B. Reported food intake and distribution of body fat: A repeated cross-sectional study. Nutr. J. 2006, 5, 34. [Google Scholar] [CrossRef] [PubMed]
  53. Cassidy, A.; Bertoia, M.; Chiuve, S.; Flint, A.; Forman, J.; Rimm, E.B. Habitual intake of anthocyanins and flavanones and risk of cardiovascular disease in men. Am. J. Clin. Nutr. 2016, 104, 587–594. [Google Scholar] [CrossRef] [PubMed]
  54. Goetz, M.E.; Judd, S.E.; Hartman, T.J.; McClellan, W.; Anderson, A.; Vaccarino, V. Flavanone intake is inversely associated with risk of incident ischemic stroke in the REasons for Geographic and Racial Differences in Stroke (REGARDS) Study. J. Nutr. 2016, 146, 2233–2243. [Google Scholar] [CrossRef] [PubMed]
  55. Wedick, N.M.; Pan, A.; Cassidy, A.; Rimm, E.B.; Sampson, L.; Rosner, B.; Willett, W.; Hu, F.B.; Sun, Q.; van Dam, R.M. Dietary flavonoid intakes and risk of type 2 diabetes in US men and women. Am. J. Clin. Nutr. 2012, 95, 925–933. [Google Scholar] [CrossRef] [PubMed]
  56. Cassidy, A.; O’Reilly, É.J.; Kay, C.; Sampson, L.; Franz, M.; Forman, J.P.; Curhan, G.; Rimm, E.B. Habitual intake of flavonoid subclasses and incident hypertension in adults. Am. J. Clin. Nutr. 2011, 93, 338–347. [Google Scholar] [CrossRef] [PubMed]
  57. Thompson, F.E.; Subar, A.F. Dietary assessment methodology. In Nutrition in the Prevention and Treatment of Disease, 3rd ed.; Coulston, A.M., Boushey, C.J., Ferruzzi, M.D., Eds.; Academic Press: San Diego, CA, USA, 2013; pp. 5–46. ISBN 9780123918857. [Google Scholar] [CrossRef]
  58. Rhodes, D.G.; Murayi, T.; Clemens, J.C.; Baer, D.J.; Sebastian, R.S.; Moshfegh, A.J. The USDA Automated Multiple-Pass Method accurately assesses population sodium intakes. Am. J. Clin. Nutr. 2013, 97, 958–964. [Google Scholar] [CrossRef] [PubMed]
  59. Maras, J.E.; Talegawkar, S.A.; Qiao, N.; Lyle, B.; Ferrucci, L.; Tucker, K.L. Flavonoid intakes in the Baltimore Longitudinal Study of Aging. J. Food Compos. Anal. 2011, 24, 1103–1109. [Google Scholar] [CrossRef] [PubMed]
  60. Pou, K.M.; Massaro, J.M.; Hoffmann, U.; Lieb, K.; Vasan, R.S.; O’Donnell, C.J.; Fox, C.S. Patterns of abdominal fat distribution: The Framingham Heart Study. Diabetes Care 2009, 32, 481–485. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  61. Garvey, W.T.; Mechanick, J.I.; Brett, E.M.; Garber, A.J.; Hurley, D.L.; Jastreboff, A.M.; Nadolsky, K.; Pessah-Pollack, R.; Plodkowski, R. Reviewers of the AACE/ACE Obesity Clinical Practice Guidelines. American Association of Clinical Endocrinologists and American College of Endocrinology comprehensive clinical practice guidelines for medical care of patients with obesity. Endocr. Pract. 2016, 22, 1–203. [Google Scholar] [CrossRef] [PubMed]
  62. Herrera, V.M.; Casas, J.P.; Miranda, J.J.; Perel, P.; Pichardo, R.; González, A.; Sanchez, J.R.; Ferreccio, C.; Aguilera, X.; Silva, E.; et al. Interethnic differences in the accuracy of anthropometric indicators of obesity in screening for high risk of coronary heart disease. Int. J. Obes. 2009, 33, 568–576. [Google Scholar] [CrossRef] [PubMed]
  63. Sobiczewski, W.; Wirtwein, M.; Jarosz, D.; Gruchala, M. Superiority of waist circumference and body mass index in cardiovascular risk assessment in hypertensive patients with coronary heart disease. Blood Press. 2015, 24, 90–95. [Google Scholar] [CrossRef] [PubMed]
  64. Peppa, M.; Koliaki, C.; Papaefstathiou, A.; Garoflos, E.; Katsilambros, N.; Raptis, S.A.; Hadjidakis, D.I.; Dimitriadis, G.D. Body composition determinants of metabolic phenotypes of obesity in nonobese and obese postmenopausal women. Obesity 2013, 21, 1807–1814. [Google Scholar] [CrossRef] [PubMed]
  65. Kent, K.; Charlton, K. Relative validity and reproducibility of an interviewer administered 14-item FFQ to estimate flavonoid intake among older adults with mild-moderate dementia. J. Nutr. Gerontol. Geriatr. 2017, 23, 1–14. [Google Scholar] [CrossRef] [PubMed]
  66. Praagman, J.; Adolphs, A.P.; van Rossum, C.T.; Sluijs, I.; van der Schouw, Y.T.; Beulens, J.W. Reproducibility and relative validity of a FFQ to estimate the intake of fatty acids. Br. J. Nutr. 2016, 115, 2154–2161. [Google Scholar] [CrossRef] [PubMed]
  67. Perovic, N.R.; Defago, M.D.; Aguinaldo, A.; Joekes, S.; Actis, A.B. Validity and reproducibility of a food frequency questionnaire to assess lipid and phytochemical intake. Rev. Fac. Cienc. Med. Univ. Nac. Cordoba 2015, 72, 69–77. [Google Scholar]
Table 1. Characteristics by quartile of total flavonoid 1 intake, adults age ≥20 years, WWEIA, NHANES 2007–2010.
Table 1. Characteristics by quartile of total flavonoid 1 intake, adults age ≥20 years, WWEIA, NHANES 2007–2010.
CharacteristicnQuartile of Flavonoid Intake 2p 3
1234
All, n10,5382819269326632363
Demographic:
 Sex, %: 0.002
  Male523245.350.750.547.8
  Female 4530654.749.349.552.2
 Age (year), %: <0.001
  20–39339342.739.034.130.2
  40–59355537.338.939.642.4
  60+359020.022.026.327.4
 Race/ethnicity, %: <0.001
  NH white 504666.867.570.474.3
  NH black 200713.511.210.29.7
  Hispanic 5300715.215.814.87.8
  Other 64784.55.54.78.2
 Income as PIR 7, %: <0.001
  0–130303726.419.816.816.3
  131–350368136.032.630.730.6
  >350288230.740.345.445.7
  Not reported9386.87.37.27.4
Lifestyle:
 Exercise status 8, %: <0.001
  Inactive/low733671.364.655.563.0
  Moderate113410.010.715.413.7
  Active206818.824.729.223.3
 Smoking status 9, %: <0.001
  Never smoker556747.653.556.555.3
  Former smoker262321.523.527.525.1
  Current smoker234830.923.016.019.6
 Self-assessed health status, %: <0.001
  Excellent/very good410140.649.352.950.1
  Good377537.631.632.233.8
  Fair/poor266221.919.114.916.0
Dietary:
 Energy, kcal (SE)10,5381816 (24)2207 (22)2304 (27)2225 10 (39)<0.001
 Dietary fiber, g (SE)10,53811.0 (0.2)16.4 (0.3)20.5 (0.3)18.3 10 (0.6)<0.001
 Added sugars, g (SE)10,53877.2 (2.6)77.8 (2.3)69.0 (2.1)84.0 (3.1)<0.001
Abbreviations: WWEIA, What We Eat in America; NHANES, National Health and Nutrition Examination Survey; NH, non-Hispanic; PIR, Poverty Income Ratio; SE, standard error. 1 Total flavonoids = sum of 29 individual flavonoids in six classes; includes anthocyanidins, flavan-3-ols (catechins, theaflavins, and thearubigins), flavanones, flavones, flavonols, and isoflavones. 2 For intake ranges by quartile, see the last two tables in this article. 3 Data were analyzed using χ2 tests for the (categorical) demographic and lifestyle characteristics and analysis of variance for the (continuous) dietary intake components. 4 Excludes pregnant and lactating females. 5 Includes Mexican Americans and other Hispanics. 6 Includes both individuals who were of races other than those listed and those who were multiracial. 7 PIR is the ratio of family income to poverty (expressed as a percentage). 8 Includes only recreational activity, with each vigorous-intensity minute counted as the equivalent of two moderate-intensity minutes; levels correspond to those in the 2008 Physical Activity Guidelines for Americans [34]. 9 Participants who reported smoking <100 cigarettes in their lives were classified as “never smokers”, those who had smoked ≥100 cigarettes but did not smoke at all at the time of the survey were classified as “former smokers”, and those who smoked cigarettes every day or some days at the time of the survey were classified as “current smokers.” 10 Significant positive linear trend across quartiles of total flavonoid intake, as determined by (first order) orthogonal polynomial contrasts (p < 0.001).
Table 2. Food/beverage groups providing ≥5% of total intake 1 of flavonoids, adults age ≥20 years, for all and by sex, WWEIA, NHANES 2007–2010.
Table 2. Food/beverage groups providing ≥5% of total intake 1 of flavonoids, adults age ≥20 years, for all and by sex, WWEIA, NHANES 2007–2010.
Flavonoid ClassRankFood/Beverage Group (% Contribution to Flavonoid Class Intake)
AllMalesFemales
Total flavonoids1Tea (78)Tea (78)Tea (78)
Anthocyanidins1Blueberries (22)Blueberries (19)Blueberries (24)
2Wine (14)Wine (16)Wine (12)
3Grapes (10)Grapes (12)Strawberries (9)
4Strawberries (8)Strawberries (7)Grapes (9)
5Miscellaneous vegetables 2 (7)Non-citrus juice other than apple, 100% (6)Miscellaneous vegetables 2 (8)
6Cranberries (6)Cranberries (5)Yogurt (6)
7Yogurt (5)Miscellaneous vegetables 2 (5)Cranberries (6)
8Non-citrus juice other than apple, 100% (5) Other berries (5)
Flavan-3-ols1Tea (94)Tea (94)Tea (94)
Flavanones1Orange juice, 100% (59)Orange juice, 100% (63)Orange juice, 100% (54)
2Oranges (19)Oranges (19)Oranges (21)
3Other citrus fruits (6) Other citrus fruits (8)
4 Fruit drinks, <100% juice (5)
Flavones1Mixed dishes (25)Mixed dishes (26)Mixed dishes (23)
2Sweet peppers (10)Sweet peppers (11)Tea (10)
3Tea (10)Tea (9)Sweet peppers (8)
4Miscellaneous vegetables 2 (7)Hot peppers (8)Miscellaneous vegetables 2 (7)
5Melons (6)Miscellaneous vegetables 2 (7)Lettuce and lettuce-based salads (6)
6Condiments and sauces, non-soy-based (6)Condiments and sauces, non-soy-based (7)Melons (6)
7Lettuce and lettuce-based salads (5)Melons (6)Parsley (6)
8Hot peppers (5)Lettuce and lettuce-based salads (5)Condiments and sauces, non-soy-based (5)
Flavonols1Tea (37)Tea (35)Tea (40)
2Mixed dishes (14)Mixed dishes (15)Mixed dishes (14)
3Beer (6)Beer (9)Apples (5)
4Onions (5)Onions (5)Onions (5)
Isoflavones1Protein powders (38)Protein powders (50)Milk substitutes (23)
2Milk substitutes (18)Milk substitutes (13)Protein powders (22)
3Processed soy products (16)Processed soy products (11)Processed soy products (22)
4Nutrition bars (8)Nutrition bars (7)Mixed dishes (11)
5Mixed dishes (8)Beans, peas, legumes (7)Nutrition bars (10)
6Beans, peas, legumes (5)Mixed dishes (5)
Abbreviations: WWEIA, What We Eat in America; NHANES, National Health and Nutrition Examination Survey. 1 For mean intakes of flavonoids by gender and age, race/ethnicity, and income, see Reference [28]. 2 The group “miscellaneous vegetables” includes vegetables that were not classified into the other, more specific groups in this analysis—namely, tomatoes, carrots, other red/orange vegetables, lettuce and lettuce-based salads, dark-green vegetables (excluding lettuce), potatoes (three groups: baked/boiled; French fries and other fried; and mashed and mixtures), corn and other starchy vegetables, onions, sweet peppers, hot peppers, celery, and parsley.
Table 3. Distribution of individuals by CVD risk class 1, adults age ≥20 years, for all and by sex, WWEIA, NHANES 2007–2010.
Table 3. Distribution of individuals by CVD risk class 1, adults age ≥20 years, for all and by sex, WWEIA, NHANES 2007–2010.
CVD Risk ClassAssociated BMI and WC 2AllMalesFemales 3
% (SE)
Average BMI < 25.031.2 (0.9)27.1 a (1.3)35.2 b (1.0)
Increased BMI 25.0–29.9, normal WC15.8 (0.5)26.3 a (0.8)5.8 b (0.4)
High+: 53.0 (1.0)46.6 a (1.3)59.1 b (1.1)
High:BMI 25.0–29.9, large WC17.9 (0.7)12.3 (0.6)23.2 (1.1)
BMI 30.0–34.9, normal WC1.3 (0.2)2.5 (0.3)0.1 (#)
Total19.2 (0.8)14.8 a (0.7)23.3 b (1.1)
Very high:BMI 30.0–34.9, large WC19.2 (0.5)20.0 (0.8)18.4 (0.7)
BMI 35.0–39.98.9 (0.4)7.6 (0.5)10.1 (0.4)
Total28.1 (0.7)27.6 (1.1)28.5 (0.7)
Extremely highBMI ≥ 40.05.8 (0.2)4.2 a (0.3)7.3 b (0.4)
Abbreviations: CVD, cardiovascular disease; WWEIA, What We Eat in America; NHANES, National Health and Nutrition Examination Survey; BMI, body mass index; WC, waist circumference; SE, standard error; high+, incorporates high, very high, and extremely high CVD risk categories. # Indicates a non-zero value too small to report. a,b Within risk class, estimates with different superscript letters differ significantly (p < 0.01). In the high risk and very high risk classes, only estimates in the “total” row were tested for significant differences. 1 CVD risk class assigned on the basis of BMI and WC, as delineated in Reference [6]. 2 BMI is reported in kg/m2. Normal WC ≤ 102 cm for men and ≤88 cm for women; large WC > 102 cm for men and >88 cm for women. 3 Excludes pregnant and lactating females.
Table 4. RR 1 of being classified at high+ CVD risk 2 by category 3 of flavonoid intake, adults age ≥20 years, WWEIA, NHANES 2007–2010.
Table 4. RR 1 of being classified at high+ CVD risk 2 by category 3 of flavonoid intake, adults age ≥20 years, WWEIA, NHANES 2007–2010.
RR by Model, by Flavonoid ClassCategory of Flavonoid Intakep for Trend 4
1234
Total flavonoids 5:
 Range of intake, mg≤19.119.2–53.153.2–230.8>230.8
 RR (99% CI):
  Model 11.000.90 (0.82, 0.99)0.82 (0.74, 0.91)0.85 (0.76, 0.96)<0.001
  Model 21.000.93 (0.85, 1.01)0.85 (0.78, 0.93)0.89 (0.80, 1.00)0.003
  Model 31.000.93 (0.86, 1.01)0.87 (0.80, 0.95)0.91 (0.82, 1.01)0.009
Anthocyanidins:
 Range of intake, mg0.00.1 6–1.81.9–10.1>10.1
 RR (99% CI):
  Model 11.000.92 (0.83, 1.02)0.89 (0.82, 0.96)0.80 (0.73, 0.89)<0.001
  Model 21.000.93 (0.84, 1.02)0.90 (0.84, 0.96)0.84 (0.77, 0.90)<0.001
  Model 3 1.000.93 (0.85, 1.03)0.92 (0.85, 0.99)0.86 (0.79, 0.93)<0.001
Flavan-3-ols:
 Range of intake, mg≤3.33.4–12.712.8–121.8>121.8
 RR (99% CI):
  Model 11.000.85 (0.78, 0.93)0.81 (0.72, 0.91)0.84 (0.75, 0.94)<0.001
  Model 21.000.86 (0.79, 0.93)0.84 (0.75, 0.95)0.87 (0.78, 0.97)0.002
  Model 31.000.86 (0.79, 0.93)0.86 (0.77, 0.96)0.88 (0.79, 0.98)0.006
Flavanones:
 Range of intake, mg0.00.1 6–0.50.6–11.8>11.8
 RR (99% CI):
  Model 11.000.99 (0.91, 1.09)0.93 (0.84, 1.03)0.85 (0.76, 0.95)<0.001
  Model 21.001.01 (0.92, 1.11)0.95 (0.87, 1.04)0.88 (0.79, 0.97)0.002
  Model 31.001.01 (0.92, 1.11)0.96 (0.88, 1.05)0.89 (0.80, 0.98)0.004
Flavones:
 Range of intake, mg≤0.10.2–0.50.6–1.1>1.1
 RR (99% CI):
  Model 11.000.96 (0.85, 1.07)0.89 (0.80, 0.99)0.91 (0.82, 1.01)0.006
  Model 21.000.97 (0.86, 1.09)0.92 (0.83, 1.02)0.96 (0.87, 1.06)0.12
  Model 31.000.98 (0.86, 1.11)0.94 (0.85, 1.04)0.99 (0.89, 1.10)0.61
Flavonols:
 Range of intake, mg≤6.36.4–13.313.4–25.7>25.7
 RR (99% CI):
  Model 11.000.92 (0.84, 1.01)0.86 (0.78 0.94)0.92 (0.81, 1.05)0.04
  Model 21.000.94 (0.86, 1.03)0.89 (0.82, 0.97)0.97 (0.85, 1.09)0.24
  Model 31.000.95 (0.87, 1.04)0.91 (0.83, 0.99)0.99 (0.88, 1.11)0.53
Abbreviations: RR, relative risk; high+ CVD risk, high, very high, or extremely high risk of cardiovascular disease; WWEIA, What We Eat in America; NHANES, National Health and Nutrition Examination Survey; CI, confidence interval. 1 RRs obtained from average marginal predictions (adjusted prevalence estimates) in the fitted logistic model [36,37]. Prevalence estimates were adjusted for the following: Model 1—energy, sex, and age (continuous); Model 2—all characteristics included in Model 1 plus race/ethnicity, income as percent of poverty, exercise status, smoking status, and health status; Model 3—all characteristics included in Model 2 plus dietary intakes of dietary fiber and added sugars. See Table 1 for explanations of characteristics. 2 Includes all those classified as being at high, very high, or extremely high risk of CVD on the basis of body mass index and waist circumference, as delineated in Reference [6]. 3 For total flavonoids, flavan-3-ols, flavones, and flavonols, intake categories are quartiles. Due to >25% of the population having zero intake of anthocyanidins (34%) and flavanones (35%), the first category for each of those classes was composed of all individuals with intake = 0.0, and those with intake >0.0 were divided into tertiles. 4 p value based on (first order) orthogonal polynomial contrasts of the adjusted prevalence estimates by category of flavonoid (total or class) intake. 5 In addition to the flavonoid classes listed in this table, total flavonoids also include isoflavones. 6 Includes non-zero intakes <0.05 mg.
Table 5. Prevalence and RR 1 of being classified at high+ CVD risk 2 by category 3 of flavonoid intake, males and females age ≥20 years, WWEIA, NHANES 2007–2010.
Table 5. Prevalence and RR 1 of being classified at high+ CVD risk 2 by category 3 of flavonoid intake, males and females age ≥20 years, WWEIA, NHANES 2007–2010.
Prevalence, and RR by Flavonoid Class and SexCategory of Flavonoid Intakep for Trend 4
1234
Total flavonoids 5:
 Male:
  Range of intake, mg≤20.220.3–54.554.6–220.4>220.4
  Prevalence, % (SE)53.1 (1.4)45.0 (2.6)42.7 (2.5)45.8 (2.0)0.005
  RR (99% CI)1.000.85 (0.73, 0.98)0.80 (0.67, 0.96)0.86 (0.75, 0.99)
 Female:
  Range of intake, mg≤17.717.8–51.651.7–240.5>240.5
  Prevalence, % (SE)61.8 (1.9)60.1 (2.0)56.4 (1.65)58.1 (1.8)0.12
  RR (99% CI)1.000.97 (0.89, 1.06)0.91 (0.82, 1.02)0.94 (0.82, 1.07)
Anthocyanidins:
 Male:
  Range of intake, mg0.00.1 6–1.71.8–7.9>7.9
  Prevalence, % (SE)49.4 (1.5)50.3 (2.2)43.2 (2.0)41.8 (2.3)<0.001
  RR (99% CI) 6 1.001.02 (0.91, 1.14)0.87 (0.77, 1.00)0.85 (0.71, 1.01)
 Female:
  Range of intake, mg0.00.1 6–1.92.0–12.7>12.7
  Prevalence, % (SE)63.3 (1.9)55.6 (2.5)62.9 (1.8)53.2 (1.6)0.002
  RR (99% CI)1.000.88 (0.75, 1.03)0.99 (0.89, 1.11)0.84 (0.76, 0.93)
Flavan-3-ols:
 Male:
  Range of intake, mg≤3.73.8–12.913.0–65.5>65.5
  Prevalence, % (SE)55.1 (1.8)42.0 (2.3)43.7 (2.4)45.8 (1.9)0.005
  RR (99% CI)1.000.76 (0.65, 0.89)0.79 (0.66, 0.96)0.83 (0.72, 0.96)
 Female:
  Range of intake, mg≤2.93.0–12.412.5–164.9>164.9
  Prevalence, % (SE)62.1 (2.0)58.7 (2.0)57.3 (1.7)58.2 (1.9)0.17
  RR (99% CI)1.000.95 (0.85, 1.05)0.92 (0.83, 1.02)0.94 (0.82, 1.07)
Flavanones:
 Male:
  Range of intake, mg0.00.1 6–0.50.6–14.5>14.5
  Prevalence, % (SE)47.4 (1.7)49.0 (2.3)46.6 (2.4)42.9 (2.2)0.06
  RR (99% CI)1.001.03 (0.90, 1.19)0.98 (0.87, 1.12)0.91 (0.78, 1.06)
 Female:
  Range of intake, mg0.00.1 6–0.50.6–9.3>9.3
  Prevalence, % (SE)61.4 (1.5)62.4 (2.6)56.5 (1.9)54.9 (2.3)0.01
  RR (99% CI)1.001.02 (0.91, 1.13)0.92 (0.82, 1.03)0.89 (0.78, 1.02)
Flavones:
 Male:
  Range of intake, mg≤0.10.2–0.50.6–1.2>1.2
  Prevalence, % (SE)48.5 (2.1)46.4 (2.2)44.4 (2.0)47.2 (2.2)0.43
  RR (99% CI)1.000.96 (0.80, 1.14)0.92 (0.80, 1.05)0.97 (0.86, 1.10)
 Female:
  Range of intake, mg≤0.10.2–0.40.5–1.0>1.0
  Prevalence, % (SE)60.0 (2.5)58.1 (2.0)57.5 (1.9)60.6 (1.5)0.89
  RR (99% CI)1.000.97 (0.84, 1.12)0.96 (0.83, 1.11)1.01 (0.89, 1.14)
Flavonols:
 Male:
  Range of intake, mg≤7.47.5–15.215.3–29.2>29.2
  Prevalence, % (SE)48.1 (1.9)44.1 (2.2)45.9 (1.7)48.3 (2.4)0.78
  RR (99% CI)1.000.92 (0.79, 1.06)0.95 (0.84, 1.08)1.00 (0.85, 1.19)
 Female:
  Range of intake mg≤5.45.5–11.711.8–23.2>23.2
  Prevalence, % (SE)59.8 (2.2)58.7 (1.7)58.0 (2.1)59.8 (2.3)0.93
  RR (99% CI)1.000.98 (0.87, 1.10)0.97 (0.85, 1.10)1.00 (0.86, 1.16)
Abbreviations: RR, relative risk; high+ CVD risk, high, very high, or extremely high risk of cardiovascular disease; WWEIA, What We Eat in America; NHANES, National Health and Nutrition Examination Survey; SE, standard error; CI, confidence interval. 1 RRs obtained from average marginal predictions (adjusted prevalence estimates) in the fitted logistic model [36,37]. Prevalence estimates were adjusted for energy, age (continuous), race/ethnicity, income as percent of poverty, exercise status, smoking status, health status, and dietary intakes of dietary fiber and added sugars. See Table 1 for explanations of characteristics. 2 Includes all those classified as being at high, very high, or extremely high risk of CVD on the basis of body mass index and waist circumference, as delineated in Reference [6]. 3 For total flavonoids, flavan-3-ols, flavones, and flavonols, intake categories are quartiles. Due to >25% of the population having zero intake of anthocyanidins (36% of males and 31% of females) and flavanones (38% of males and 33% of females), the first category for each of those classes was composed of all those with intake = 0.0, and those with intake >0.0 were divided into tertiles. 4 p value based on (first order) orthogonal polynomial contrasts of the adjusted prevalence estimates by category of flavonoid (total or class) intake. 5 In addition to the flavonoid classes listed in this table, total flavonoids also include isoflavones. 6 Includes non-zero intakes <0.05 mg.

Share and Cite

MDPI and ACS Style

Sebastian, R.S.; Wilkinson Enns, C.; Goldman, J.D.; Moshfegh, A.J. Dietary Flavonoid Intake Is Inversely Associated with Cardiovascular Disease Risk as Assessed by Body Mass Index and Waist Circumference among Adults in the United States. Nutrients 2017, 9, 827. https://doi.org/10.3390/nu9080827

AMA Style

Sebastian RS, Wilkinson Enns C, Goldman JD, Moshfegh AJ. Dietary Flavonoid Intake Is Inversely Associated with Cardiovascular Disease Risk as Assessed by Body Mass Index and Waist Circumference among Adults in the United States. Nutrients. 2017; 9(8):827. https://doi.org/10.3390/nu9080827

Chicago/Turabian Style

Sebastian, Rhonda S., Cecilia Wilkinson Enns, Joseph D. Goldman, and Alanna J. Moshfegh. 2017. "Dietary Flavonoid Intake Is Inversely Associated with Cardiovascular Disease Risk as Assessed by Body Mass Index and Waist Circumference among Adults in the United States" Nutrients 9, no. 8: 827. https://doi.org/10.3390/nu9080827

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop